Autonomix Medical to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting

Autonomix Medical will present new long-term pain mitigation data in pancreatic cancer at the Society of Surgical Oncology (SSO) 2026 Annual Meeting. The presentation, titled "Pain Mitigation in Pancreatic Adenocarcinoma," has been accepted as an oral podium presentation. The data highlights the potential of Autonomix Medical's minimally invasive transvascular RF energy-based approach to address chronic pain in pancreatic cancer patients. The SSO Annual Meeting convenes leading surgical oncologists and healthcare professionals to showcase advances in surgical oncology.